<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.prmcm.2022.100043"><dct:format>application/xml</dct:format><dct:title>Total ginsenoside and Acorus tatarinowii volatile oil co-administration reverses learning memory deficits, reduces A&#x03b2;42 and AChE levels, and downregulates the PI3K/Akt/mTOR/Beclin-1 autophagic pathway in APP/PS1 double transgenic mice</dct:title><dct:creator>Minzhen Deng</dct:creator><dct:creator>Xiaoqin Zhong</dct:creator><dct:creator>Baile Ning</dct:creator><dct:creator>Qinxin Zhang</dct:creator><dct:creator>Yongqi Fang</dct:creator><dct:creator>Liping Huang</dct:creator><dct:subject><rdf:Bag><rdf:li>Total ginsenoside</rdf:li><rdf:li>Volatile oil of Acorus tatarinowii</rdf:li><rdf:li>Autophagy</rdf:li><rdf:li>APP/PS1 double transgenic mice</rdf:li></rdf:Bag></dct:subject><dct:description>Pharmacological Research - Modern Chinese Medicine 2 (2022). doi:10.1016/j.prmcm.2022.100043</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Pharmacological Research - Modern Chinese Medicine</prism:publicationName><prism:copyright>&#169; 2022 Published by Elsevier B.V.</prism:copyright><dct:publisher>Elsevier B.V.</dct:publisher><prism:issn>2667-1425</prism:issn><prism:volume>2</prism:volume><prism:coverDisplayDate>March 2022</prism:coverDisplayDate><prism:doi>10.1016/j.prmcm.2022.100043</prism:doi><prism:url>http://dx.doi.org/10.1016/j.prmcm.2022.100043</prism:url><dct:identifier>doi:10.1016/j.prmcm.2022.100043</dct:identifier><bam:articleNumber>100043</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2022-01-07T10:32:31Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#ElsevierWaived</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S250.1</dp:version-number></dp:document-properties><ja:article docsubtype="fla" version="5.6" xml:lang="en"><ja:item-info><ja:jid>PRMCM</ja:jid><ja:aid>100043</ja:aid><ce:article-number>100043</ce:article-number><ce:pii>S2667-1425(22)00004-5</ce:pii><ce:doi>10.1016/j.prmcm.2022.100043</ce:doi><ce:copyright type="unknown" year="2022"/></ja:item-info><ja:head><ce:title id="tte0002">Total ginsenoside and <ce:italic>Acorus tatarinowii</ce:italic> volatile oil co-administration reverses learning memory deficits, reduces A&#x03b2;<ce:inf loc="post">42</ce:inf> and AChE levels, and downregulates the PI3K/Akt/mTOR/Beclin-1 autophagic pathway in APP/PS1 double transgenic mice</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2667142522000045-b7e6c81317b25b3cbe745520486b6c45"><ce:given-name>Minzhen</ce:given-name><ce:surname>Deng</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="fn1"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:422172970@qq.com">422172970@qq.com</ce:e-address></ce:author><ce:author id="au0002" author-id="S2667142522000045-38a3b9e20e83a4bb847841054662064e"><ce:given-name>Xiaoqin</ce:given-name><ce:surname>Zhong</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role><ce:cross-ref refid="aff0003"><ce:sup loc="post">c</ce:sup></ce:cross-ref><ce:cross-ref refid="fn1"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2667142522000045-0e2421ef82be6d02f56fe379bbf64d4a"><ce:given-name>Baile</ce:given-name><ce:surname>Ning</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/software">Software</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2667142522000045-83e1997c14f9ccb323c0a4529816dee6"><ce:given-name>Qinxin</ce:given-name><ce:surname>Zhang</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S2667142522000045-7487703bc3e34bdcb6f700699dc24dd9"><ce:given-name>Yongqi</ce:given-name><ce:surname>Fang</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/project-administration">Project administration</ce:contributor-role><ce:cross-ref refid="aff0003"><ce:sup loc="post">c</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0002" type="email" xlink:href="mailto:fangyq2@163.com">fangyq2@163.com</ce:e-address></ce:author><ce:author id="au0006" author-id="S2667142522000045-0eff6b9f376f7cbdbb4302c867b3f4b0"><ce:given-name>Liping</ce:given-name><ce:surname>Huang</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/project-administration">Project administration</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:cross-ref refid="aff0004"><ce:sup loc="post">d</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0003" type="email" xlink:href="mailto:xiaolyinlanlp@126.com">xiaolyinlanlp@126.com</ce:e-address></ce:author><ce:affiliation id="aff0001" affiliation-id="S2667142522000045-59363f9ab382410f505ae62b909e06f2"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, PR China</ce:textfn><sa:affiliation><sa:organization>Department of Neurology</sa:organization><sa:organization>Guangdong Provincial Hospital of Chinese Medicine</sa:organization><sa:organization>The Second Affiliated Hospital of Guangzhou University of Chinese Medicine</sa:organization><sa:city>Guangzhou</sa:city><sa:postal-code>510120</sa:postal-code><sa:country>PR China</sa:country></sa:affiliation><ce:source-text id="staff0001">aDepartment of Neurology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, PR China</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2667142522000045-431d1df243ee7d8fab2652a63c32b018"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Postdoctoral Research Station of Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, PR China</ce:textfn><sa:affiliation><sa:organization>Postdoctoral Research Station of Guangdong Provincial Hospital of Chinese Medicine</sa:organization><sa:city>Guangzhou</sa:city><sa:postal-code>510120</sa:postal-code><sa:country>PR China</sa:country></sa:affiliation><ce:source-text id="staff0002">bPostdoctoral Research Station of Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, PR China</ce:source-text></ce:affiliation><ce:affiliation id="aff0003" affiliation-id="S2667142522000045-4f5f354de63ae083125254745e8163a7"><ce:label>c</ce:label><ce:textfn id="cetextfn0003">The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, PR China</ce:textfn><sa:affiliation><sa:organization>The First Clinical Medical College of Guangzhou University of Chinese Medicine</sa:organization><sa:city>Guangzhou</sa:city><sa:postal-code>510405</sa:postal-code><sa:country>PR China</sa:country></sa:affiliation><ce:source-text id="staff0003">cThe First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, PR China</ce:source-text></ce:affiliation><ce:affiliation id="aff0004" affiliation-id="S2667142522000045-d548b540d9a9851e3cd83f555f7e39ba"><ce:label>d</ce:label><ce:textfn id="cetextfn0004">School of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang 524048, PR China</ce:textfn><sa:affiliation><sa:organization>School of Chemistry and Chemical Engineering</sa:organization><sa:organization>Lingnan Normal University</sa:organization><sa:city>Zhanjiang</sa:city><sa:postal-code>524048</sa:postal-code><sa:country>PR China</sa:country></sa:affiliation><ce:source-text id="staff0004">dSchool of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang 524048, PR China</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author.</ce:text></ce:correspondence><ce:footnote id="fn1"><ce:label>1</ce:label><ce:note-para id="notep0001" view="all">These authors contributed equally to this work and should be considered as co-first authors.</ce:note-para></ce:footnote></ce:author-group><ce:date-received day="14" month="9" year="2021"/><ce:date-revised day="8" month="12" year="2021"/><ce:date-accepted day="7" month="1" year="2022"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:section-title id="cesectitle0002">Ethnopharmacological Relevance</ce:section-title><ce:simple-para id="spara011" view="all">The combined application of ginseng and Shichangpu comes from the nootropic prescription&#x2014;Dingzhi Xiaowan. One of the main effective components of ginseng is saponins. Studies have reported that its total saponins have significant neuroprotective effects, especially in anti-neuro-inflammation and anti-cognitive impairment. Shichangpu is a traditional Chinese medicine commonly used in clinical treatment of mental disorders such as dementia, amnesia, and epilepsy. One of the main active ingredients of <ce:italic>Acorus tatarinowii</ce:italic> is volatile oil, and research reports that its volatile oil also has a good neuroprotective effect. Previous research by the research team has shown its potential efficacy against Alzheimer's disease (AD).</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0002" view="all"><ce:section-title id="cesectitle0003">Aim of the study</ce:section-title><ce:simple-para id="spara012" view="all">At present, the pathogenesis of Alzheimer's disease (AD) is not yet clear and the current treatment methods can only relief the related symptoms of AD. Our previous research found that the volatile oil of <ce:italic>Acorus tatarinowii</ce:italic> and components of ginsenosides, such as Rd, Rh2 and Rg1 can improve the learning and memory ability of AD mice. However, the effect and mechanism of volatile oil of <ce:italic>Acorus tatarinowii</ce:italic> combined with total ginsenosides on APP/PS1 double transgenic mice are still unknown.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0003" role="materials-methods" view="all"><ce:section-title id="cesectitle0004">Materials and methods</ce:section-title><ce:simple-para id="spara013" view="all">In this study, the effects of total ginsenoside and <ce:italic>Acorus tatarinowii</ce:italic> volatile oil co-administration on behavioral tests, amyloid &#x03b2; 42 (A&#x03b2;42) and acetylcholinesterase (AChE) levels, p-Akt, p-mTOR, LC3B, Bcl-2 and p62 expressions were investigated in APP/PS1 double transgenic mice. Furthermore, the PI3K/Akt/mTOR autophagic pathway was also studied and the structure of hippocampal neurons was observed.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0004" role="results" view="all"><ce:section-title id="cesectitle0005">Results</ce:section-title><ce:simple-para id="spara014" view="all">The results showed that co-administrated treatment improved the learning and memory ability of mice in the water maze, passive avoidance and step-down tests, the swimming time and error times were shorten and incubation period was prolonged. And A&#x03b2;<ce:inf loc="post">42</ce:inf> and AChE levels decreased, LC3B and Beclin-1 expressions declined, and number of autophagosomes reduced in the hippocampus of the APP/PS1 double transgenic mice, in contrary, the change of p-Akt, p-mTOR, P62 and Bcl-2 expressions were increased in the co-administrated treated mice compared with the untreated mice. We deduced that co-administrated therapy may firstly upregulate expressions of p-Akt, p-mTOR, P62 and Bcl-2, and then indirectly decrease the expression of LC3B and Beclin-1.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0005" role="conclusion" view="all"><ce:section-title id="cesectitle0006">Conclusion</ce:section-title><ce:simple-para id="spara015" view="all">Collectively, all data indicated that total ginsenoside and <ce:italic>Acorus tatarinowii</ce:italic> volatile oil co-administration may play an autophagy inhibited role in preventing AD development by the PI3K/Akt/mTOR pathway.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract id="abs0002" class="graphical" view="all"><ce:section-title id="cesectitle0007">Graphical abstract</ce:section-title><ce:abstract-sec id="abss0007" view="all"><ce:simple-para id="spara016" view="all"> [Display omitted] </ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0008">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Total ginsenoside</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Volatile oil of <ce:italic>Acorus tatarinowii</ce:italic></ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Autophagy</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">APP/PS1 double transgenic mice</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
